Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000935836-25-000496·AYTU BIOPHARMA, INC
Schedule 13G ownership disclosure
Aytu BioPharma Inc
Common Stock · CUSIP: 054754858
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Stonepine Capital Management, LLC
Shares: 906,063.00 · Class: 9.9%
- Stonepine Capital, L.P.
Shares: 906,063.00 · Class: 9.9%
- Stonepine GP, LLC
Shares: 906,063.00 · Class: 9.9%
- Jon M. Plexico
Shares: 906,063.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000496
- Form type
- SCHEDULE 13G/A
- Filer
- AYTU BIOPHARMA, INC
- CIK
- CIK 1385818
- Filed
- Aug 13, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership